Barclays’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-92
| Closed | -$6K | – | 3969 |
|
|
2021
Q3 | $6K | Sell |
92
-69
| -43% | -$4.5K | ﹤0.01% | 3818 |
|
|
2021
Q2 | $13K | Sell |
161
-396
| -71% | -$32K | ﹤0.01% | 3806 |
|
|
2021
Q1 | $74K | Buy |
557
+342
| +159% | +$45.4K | ﹤0.01% | 3451 |
|
|
2020
Q4 | $34K | Sell |
215
-88
| -29% | -$13.9K | ﹤0.01% | 3299 |
|
|
2020
Q3 | $31K | Sell |
303
-61
| -17% | -$6.24K | ﹤0.01% | 3421 |
|
|
2020
Q2 | $45K | Buy |
364
+155
| +74% | +$19.2K | ﹤0.01% | 3433 |
|
|
2020
Q1 | $16K | Sell |
209
-427
| -67% | -$32.7K | ﹤0.01% | 3427 |
|
|
2019
Q4 | $187K | Buy |
636
+307
| +93% | +$90.3K | ﹤0.01% | 3210 |
|
|
2019
Q3 | $59K | Sell |
329
-37
| -10% | -$6.64K | ﹤0.01% | 3629 |
|
|
2019
Q2 | $146K | Buy |
366
+177
| +94% | +$70.6K | ﹤0.01% | 3379 |
|
|
2019
Q1 | $88K | Buy |
+189
| New | +$88K | ﹤0.01% | 3396 |
|
|
2018
Q4 | – | Sell |
-210
| Closed | -$143K | – | 4515 |
|
|
2018
Q3 | $143K | Buy |
210
+171
| +438% | +$116K | ﹤0.01% | 3232 |
|
|
2018
Q2 | $27K | Buy |
+39
| New | +$27K | ﹤0.01% | 3531 |
|